(Press-News.org) The American Thyroid Association® (ATA®) is pleased to announce that Trevor E. Angell, MD has been selected as the new Editor-in-Chief of the ATA monthly journal Clinical Thyroidology®. Dr. Angell’s term as Editor-in-Chief will begin in January 2024.
Clinical Thyroidology is one of the ATA’s official journals and is published in partnership with Mary Ann Liebert, Inc. This highly valued abstract and commentary publication provides a comprehensive look at clinical thyroid literature. Experts in the field summarize the most innovative, relevant articles and provide insight into the relevance and impact of each article on patient care.
‘I am delighted that Dr. Angell has agreed to take over the reigns as Editor in Chief of Clinical Thyroidology, following the superb job that Dr. Leung has done. I have every confidence that Dr. Angell will continue the clear upward trajectory of the journal,” said Christopher McCabe, American Thyroid Association’s Secretary.
Dr. Angell will succeed Angela M. Leung, MD, who is completing a five-year term as Editor-in-Chief of Clinical Thyroidology. Clinical Thyroidology has seen a growth in readership and downloads during Dr. Leung’s term and the American Thyroid Association is grateful for her strategic and innovative leadership.
“I am thrilled to have the opportunity to be Editor-in-Chief of Clinical Thyroidology following the exceptional tenure of Dr. Angela Leung. I plan to continue to work with an outstanding editorial board, contributing expertise and thought-leading commentaries, to create this unique and invaluable publication,” said Dr. Angell.
Dr. Angell is an Associate Professor of Clinical Medicine in the Department of Medicine’s division of endocrinology and diabetes at Keck School of Medicine of USC. Dr. Angell is board certified in internal medicine and diabetes, endocrinology, and metabolism. His clinical and research interest is the diagnosis and treatment of thyroid diseases. He is nationally recognized for research and clinical expertise in thyroid nodule evaluation and molecular testing of thyroid nodules.
About the Journal
Clinical Thyroidology® monthly expert commentary provides an expansive look at clinical thyroid literature and summarizes the most innovative, relevant articles that clinicians should know about. Complete tables of content may be viewed on the Clinical Thyroidology website.
About the American Thyroid Association
The American Thyroid Association® (ATA) is dedicated to transforming thyroid care through clinical excellence, education, scientific discovery, and advocacy in a collaborative community. ATA® is an international professional medical society with more than 1,700 members from 70 countries around the world.
The ATA® promotes thyroid awareness and information through its online Clinical Thyroidology® for the Public (distributed free of charge to over 12,000 patients and public subscribers) and extensive, authoritative explanations of thyroid disease and thyroid cancer in both English and Spanish. The ATA® website www.thyroid.org serves as a bonafide clinical resource for patients and the public who look for reliable information on the Internet.
About Mary Ann Liebert
Mary Ann Liebert, Inc., is known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research. A complete list of the firm’s more than 90 journals, books, and newsmagazines is available on its website.
END
American Thyroid Association® names Trevor E. Angell, MD new Editor-in-Chief of Clinical Thyroidology®
2023-11-02
ELSE PRESS RELEASES FROM THIS DATE:
Hollings researchers uncover new targets for breast cancers resistant to standard therapies
2023-11-02
Researchers at MUSC Hollings Cancer Center believe that some drugs already approved by the U.S. Food and Drug Administration or currently in clinical trials could be repurposed for certain breast cancer patients whose cancer has become resistant to standard therapies.
Ozgur Sahin, Ph.D., a professor and SmartState Endowed Chair in the Department of Biochemistry and Molecular Biology, led the research, which was published Nov. 2 in Nature Communications.
The research, funded by an American Cancer Society Research Scholar Grant, started as an investigation into cancer resistance to the drug tamoxifen but expanded as the research questions led down new ...
Start-up dedicated to developing new antibiotics
2023-11-02
It all began with basic research: While conducting laboratory experiments, a team at the Technical University of Munich (TUM) came across an active agent against multidrug-resistant bacteria with a fundamental difference to antibiotics developed to date. The researchers have since established a start-up to develop a new drug based on this agent. The entrepreneurs have now been nominated for Science Breakthrough of the Year in the Science Start-Up category at the international Falling Walls summit.
Rising numbers of bacteria are developing ...
Two million European households could abandon the electrical grid by 2050
2023-11-02
Researchers report that 53% of European freestanding homes could have supplied all their own energy needs in 2020 using only local rooftop solar radiation, and this technical feasibility could increase to 75% in 2050. Publishing November 2 in the journal Joule, the study shows that there is no economic advantage for individual households to be fully self-sufficient under current or future conditions, though in some cases the costs are on par with remaining on-grid. The researchers estimate that self-sufficiency will be economically feasible for 5% (two million) of Europe’s 41 million freestanding single-family homes in 2050, ...
One sleepless night can rapidly reverse depression for several days
2023-11-02
All-nighters can cause giddy and slap-happy feelings
This effect is caused by increased dopamine release in distributed brain regions
This dopamine signal also enhances plasticity in the neuronal connections, causing a potent antidepressant effect that lasts for days
Study suggests that prefrontal cortex and its dopamine inputs are key for rapid plasticity and antidepressant effects after brief sleep loss
EVANSTON, Ill. — Most people who have pulled an all-nighter are all too familiar with that “tired and wired” ...
Circuit-specific gene therapy brings new hope for treatment of Parkinson’s disease
2023-11-02
Researchers from the Shenzhen Institute of Advanced Technology (SIAT) of the Chinese Academy of Sciences (CAS) and their collaborators have developed a gene therapy strategy to selectively manipulate Parkinson's disease-affected circuitry and attenuate the core motor symptoms of Parkinson's disease in rodent and nonhuman primate animals.
The study was published in Cell on Nov. 2.
Parkinson's disease, characterized by the loss of midbrain dopaminergic neurons, is one of the most common neurodegenerative diseases in the elderly population, affecting more than 6 million people worldwide.
Dopamine ...
Higher risk of breast cancer in women with false positive mammography result
2023-11-02
Women who receive a false positive mammography result are more likely to develop breast cancer over the subsequent 20 years, report researchers from Karolinska Institutet in a study published in JAMA Oncology. The risk is highest for women aged between 60 and 75 and who have low breast density.
In global terms, breast cancer is the most common form of cancer among women, and screening is an important tool for catching women with a tumour at the earliest possible stage. In Sweden, all women between ...
PTSD symptoms and cardiovascular and brain health in women
2023-11-02
About The Study: In this study of 274 midlife women, greater posttraumatic stress disorder (PTSD) symptoms were associated with higher carotid atherosclerosis and, among women who were APOEɛ4 carriers, greater brain small vessel disease and poorer cognitive performance. These findings point to the adverse implications of PTSD symptoms for cardiovascular and neurocognitive health among women in midlife, particularly for women who are APOEɛ4 carriers.
Authors: Rebecca C. Thurston, Ph.D., of the University of Pittsburgh, is the corresponding author.
To access the embargoed ...
Breast cancer incidence after a false-positive mammography result
2023-11-02
About The Study: The findings of this study suggest that the risk of developing breast cancer after a false-positive mammography result differs by individual characteristics and follow-up. These findings can be used to develop individualized risk-based breast cancer screening after a false-positive result.
Authors: Xinhe Mao, M.Sc., of the Karolinska Institutet in Stockholm, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamaoncol.2023.4519)
Editor’s Note: Please ...
Practicing mindfulness can help people make heart-healthy eating choices
2023-11-02
PROVIDENCE, R.I. [Brown University] — Practicing mindfulness focused on healthy eating can be good for the heart, a new study shows, because it improves self-awareness and helps people stick to a heart-healthy diet.
When people who had elevated blood pressure participated in an eight-week mindfulness-based blood pressure reduction program for the study, they significantly improved their scores on measures of self-awareness and adherence to a heart-healthy diet compared to a control group. The results were published in JAMA Network Open.
“Participants ...
Infirmary Health partners with Ochsner Accountable Care Network to improve health outcomes for seniors across the Gulf Coast
2023-11-02
NEW ORLEANS, LA- Ochsner Health, the leading healthcare system in the Gulf South, and Infirmary Health, Alabama's largest private non-profit healthcare provider, are proud to announce a landmark partnership with Ochsner Accountable Care Network, a top-performing accountable care organization (ACO) in both clinical performance and healthcare savings for the Medicare population. The partnership aims to improve health outcomes for seniors across the Gulf Coast region.
Infirmary Health's hospitals and acute care facilities are recognized as national leaders in innovative and compassionate care for ...